Cc1ccc(Cn2c(C)cc3c(c2=O)C(c2cccs2)C(C#N)=C(N)O3)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?